Financial & competing interests disclosure
The authors are supported by grants from the Juvenile Diabetes Research Foundation, the Dutch Diabetes Research Foundation, The Netherlands Organization for Health Research and Development (ZonMW: VICI award) and the European Union (EU-FP7 Framework, NAIMIT, BetaCellTherapy & EE-ASI). BO Roep has consulted for Diamyd Medical, Andromeda Biotech, Novo Nordisk AS, GSK and Lilly and received financial support for mechanistic studies from Bayhill Therapeutics. The authors have no other relevant affiliations or financial involvement with any organization or entity with a financial interest in or financial conflict with the subject matter or materials discussed in the manuscript apart from those disclosed.
No writing assistance was utilized in the production of this manuscript.